NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
Subsidiary Legislation made under rr. 2 and 3(5) of the Medicines (Prescription Only) Regulations 1987.
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Revoked by LN. 2013/192 as from 19.12.2013 (LN. 2012/085) 14.6.2012 _______________________ In accordance with regulations 2 and 3(5) of the Medicines (Prescription Only) Regulations 1987 the Chairman of the Gibraltar Health Authority has made the following notice− The following products are approved as “nurse practitioner medicinal products”− RESPIRATORY SYSTEM BRONCHODILATORS (SABA ) Salbutamol
Government of Gibraltar (www.gibraltarlaws.gov.gi)
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
PEAK FLOW METERS - standard and low range
250mg 500mg 125mg/5ml 250mg/5ml 250mg sachet
Government of Gibraltar (www.gibraltarlaws.gov.gi)
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
Government of Gibraltar (www.gibraltarlaws.gov.gi)
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
Oilatum Oilatum plus E45 Aveeno Epaderm Doublebase gel
Government of Gibraltar (www.gibraltarlaws.gov.gi)
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
(Hedrin)/Full marks Solution/malathion 0.5%
NICOTINE DEPENDENCE THERAPY Varenicline 500 ug (Champix) NERVOUS SYSTEM Prochloperazine 5mg buccal tablets; 3mg (Stemetil) Aspirin 75mg; 300mg EC and Dispersible Paracetamol 500mg paediatric solution 120mg/5ml 250mg/5ml Co-codamol 8/500 30/500 Codeine phosphate 30mg DIABETES: Metformin tablets (Glucophage) Metformin Modified Release tablet Glucophage SR) Glibenclamide Gliclazide Modified Release (Diamicron MR) Glimipiride (Amaryl)
Government of Gibraltar (www.gibraltarlaws.gov.gi)
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
Glipizide (Minodiab) Tolbutamide Pioglitazone (Actos) STATINS Simvastatin 10 mg 20 40 mg (monitor liver function test) HYPERTENSION Bendroflumethiazide 2.5 5mg titrate according to response monitor kidney function Ramipril 1.25 2.55 10mg titrate according to response DIABETES TREATMENT Biguanides Metformin tablets (Glucophage) Metformin Modified Release tablets (Glucophage SR) Sulfonylureas Glibenclamide Gliclazide Modified Release (Diamicron MR) Glimipiride (Amaryl) Glipizide (Minodiab) Tolbutamide Thiazlodinedione Pioglitazone (Actos) Pioglitazone and metformin combined (Competact) DPP4 Inhibitors Saxagliptin (Onglyza) Sitagliptin (Januvia) Sitagliptin and metformin combined (Janumet) Vildagliptin (Galvus) Vildagliptin and metformin combined (Eucreas) OTHER ORAL MEDICATIONS Acarbose (Glucobay) Nateglinide (Starlix) GLP-1 Inhibitors (injectable therapy) Exenatide (Byetta) Exenatide modified release (Bydureon) Liraglutide (Victoza) INSULINS Hypurin Actrapid Humulin S Insuman Rapid Novorapid
Government of Gibraltar (www.gibraltarlaws.gov.gi)
NOTICE OF NURSE PRACTITIONER MEDICINAL PRODUCTS Subsidiary 2012/085
Insulin Glulisine (Apidra) Insulin Lispro (Humalog) Insulin Detemir (Levemir) Insulin Glargine (Lantus) Isophane Insulin (Unsulatard Humulin I Insuman Basal) Biphasic Insulin Aspart (Novomix 30) Biphasic Insulin Lispro (Humalog Mix 30) Biphasic Isophane Insulin (Humulin M3;Insuman Comb 15; Insuman Comb 25; Insuman Comb 50) CONSUMABLES Needles (Eg Novofine) Finger pricking devices (Eg Unistix Accu-chek multiclix) Test strips (Eg Accu-chek aviva) Insulin Pen devices (as above) Clinistix Ketostix Hypoglycaemia Treatments Glucogel Glucagon kit Diazoxide Conditions− All prescribing must be within the doses timings and advice of the BNF Guidelines as published from time by BNF Management and the current version of the BNF is deemed the version in operation. Those nurse practitioners permitted to prescribe are those who are registered as prescribing Nurse Practitioners by the Nursing and Midwifery Council UK. The above list is in addition to the power to prescribe repeat prescriptions in accordance with regulation 3(5)(b) of the Medicines (Prescription Only) Regulations 1987. In such cases dosages of those medications may be adjusted within the BNF Guidelines mentioned above. Pharmacy reimbursement through the GPMS for any prescribing by Nurse Practitioners is the same as for prescribing by Gibraltar Registered Medical Practitioner practicing within the GHA.
Government of Gibraltar (www.gibraltarlaws.gov.gi)
Original Article Nepal Journal of Neuroscience 3: 80-84, 2007 Neurocysticercosis: A Review Amit Agarawal, MCh Department of Surgery Neurocysticercosis (NCC) is the most common parasiticdisease of the central nervous system and is a major causeof epilepsy and neurological morbidity in endemic areas ofthe world. International travel and immigration are bringing Guru Prasad Khanal, MS